Lifestyle choices and freedoms limit effectiveness of public health interventions

Data from study about choices mothers make about feeding their babies inform public lecture at University of Leicester

2010-10-06

(Press-News.org) The Government's ability to intervene directly to protect people's health and well-being has reached its limits in modern society because the health issues of today are closely tied in with individual lifestyle choice and freedoms, a leading academic will say today (October 5).

Public health issues have previously been more amenable to government intervention and included improving sanitation or air quality, or controlling infectious disease. But public health issues today, like smoking, drink and diet, have meant that legislation is a blunt instrument in tackling these problems.

In her inaugural lecture Professor Elizabeth Murphy, Pro-Vice-Chancellor and Head of the University of Leicester's College of Social Science will also address issues of civil liberty, individual choice and privacy in limiting the effectiveness of Government to address public health issues.

Professor Murphy will compare the relative powerlessness of governments today to affect lifestyle choices contributing to conditions such as cancer, cardiovascular disease and diabetes, with major strides forward In the 19th and 20th centuries in public health policies that helped to eradicate infectious diseases through large-scale programmes to improve sanitation, hygiene and air and water quality.

Professor Murphy will argue that many of today's problems cannot be solved by legislation – a point acknowledged by Prime Minister David Cameron in a speech last year, when he observed that "when it comes to public health, you can't just reach for the levers of legislation ... the public health problems of today are increasingly the consequence of perfectly legal personal decisions made in private spaces."

Professor Murphy said: "I will explore how it is possible within states committed to respect for the autonomy and privacy of individuals, to promote the health and welfare of the population without riding roughshod over individual choice and freedom."

Her lecture will draw on data from a study about the choices mothers make about feeding their babies during the first two years of their lives, including whether to breast or bottle feed. She will consider how mothers endorse, negotiate, resist, reconstruct and refuse expert advice about infant nutrition.

"I shall discuss the ways in which health-related lifestyle choices have become increasingly moralised so that failure to conform to expert advice about health-promoting behaviours raises questions about one's standing as a fit and proper person," she added.

### For more information, please contact:

Ather Mirza
Press Office
University of Leicester
Tel: 0116 252 3335
Mob: 07711 927821
Email: pressoffice@le.ac.uk

Notes to editors

Professor Murphy joined the University of Leicester in 2009, where she is Professor of Sociology, Pro-Vice Chancellor and Head of the College of Social Science. She was previously based at the University of Nottingham, where she was Professor of Medical Sociology and Head of the School of Sociology and Social Policy.

The lecture will be held on Tuesday October 5 at 5.30pm in Lecture Theatre 1 in the Ken Edwards Building. It will be followed by a reception in the Park Side Lounge on the fifth floor of the Charles Wilson Building.

For more information or to confirm your attendance, please contact: pressoffice@le.ac.uk

ELSE PRESS RELEASES FROM THIS DATE:

Anti-tumor drugs tested by microfluidic device

2010-10-06

Washington, D.C. (October 5, 2010) -- A prototype device developed in Hong Kong will allow laboratory researchers to non-invasively test drugs for their ability to kill tumors by subjecting cancerous cells with different concentration gradients. The new device is built upon microfluidics -- a set of technologies that allows the control and manipulation of fluids at the sub-millimeter scale -- and is described in the American Institute of Physics' journal Biomicrofluidics. Microfluidic valves within the device, said Hongkai Wu of Hong Kong University of Science and Technology, ...

For future chips, smaller must also be better

2010-10-06

Washington, D.C. (October 5, 2010) -- The explosion of portable communication devices that we enjoy today -- such as cell and smart phones, Bluetooth hands-free units, and wireless Internet networks -- has resulted in part from the development of a wide variety of integrated circuits that create, process and receive the microwave frequencies on which the communication is based. Continuing demand for higher performance over a wider range of frequencies has shrunk the physical size of circuits and fueled the development of new materials in thin-film forms, tested in detail ...

Model unfolds proteins gently

2010-10-06

Washington, D.C. (October 5, 2010) -- Protein molecules inside cells are constantly reorganizing themselves, driven by very tiny forces exerted by all the other molecules in their crowded environment. Most experimental techniques and theoretical/computational models are necessarily built around much greater driving forces. A new theoretical model reported in the Journal of Chemical Physics investigates the unfolding of fibronectin under gentler conditions. "Typical models study very fast processes and consume a lot of CPU time," says author Alessandro Pelizzola of the ...

The effects of hydrogen on growing carbon nanotubes

2010-10-06

Washington, D.C. (October 5, 2010) -- Carbon nanotubes -- long, hollow cylinders of carbon billionths of a meter in diameter -- have many potential uses in nanotechnology, optics, electronics, and many other fields. The exact properties of nanotubes depend on their structure, and scientists as yet have little control over that structure, which is determined during the initial formation -- or growth -- of the nanotubes. In fact, says chemical engineer and materials scientist Eray Aydil of the University of Minnesota, "we do not know precisely how the nanotubes grow." In ...

CAMH selected as field trial site for DSM-5

2010-10-06

For Immediate Release - (October 5, 2010) –Toronto's Centre for Addiction and Mental Health (CAMH) has been selected as one of seven adult field trial sites in North America and the only site in Canada to test proposed diagnostic criteria for the American Psychiatric Association's (APA) fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM). Used by health professionals around the world, DSM is the manual that provides descriptions, symptoms and other criteria for diagnosing mental disorders. CAMH is participating in field trials to help assess ...

T cell discovery shows promise for type 1 diabetes treatment: UBC-CFRI study

2010-10-06

A research team from the University of British Columbia and the Child & Family Research Institute (CFRI) at BC Children's Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients. Also known as juvenile diabetes, type 1 diabetes is an autoimmune disease primarily affecting children and young adults. In patients with type 1 diabetes, the body attacks itself by destroying insulin-producing cells in the pancreas that regulate glucose, or blood sugar. Led by Rusung Tan, a Pathology professor in the ...

Science survey ranks top biopharma employers

2010-10-06

### For the complete business office feature with individual company rankings, go to dx.doi.org/10.1126/science.opms.r1000097. The article will be posted at this URL address the evening of 7 October 2010. The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society, and publisher of the journal, Science (www.sciencemag.org) as well as Science Translational Medicine (www.sciencetranslationalmedicine.org) and Science Signaling (www.sciencesignaling.org). AAAS was founded in 1848, and includes some 262 affiliated ...

Bricks made with wool

2010-10-06

Spanish and Scottish researchers have added wool fibres to the clay material used to make bricks and combined these with an alginate, a natural polymer extracted from seaweed. The result is bricks that are stronger and more environmentally-friendly, according to the study published recently in the journal Construction and Building Materials. "The objective was to produce bricks reinforced with wool and to obtain a composite that was more sustainable, non-toxic, using abundant local materials, and that would mechanically improve the bricks' strength", Carmen Galán and ...

Neanderthals had feelings too, say University of York researchers

2010-10-06

Pioneering new research by archaeologists at the University of York suggests that Neanderthals belied their primitive reputation and had a deep seated sense of compassion. A team from the University's Department of Archaeology took on the 'unique challenge' of charting the development of compassion in early humans. The researchers examined archaeological evidence for the way emotions began to emerge in our ancestors six million years ago and then developed from earliest times to more recent humans such as Neanderthals and modern people like ourselves. The research by ...

Umbilical cord blood not suitable for assessing allergy risk

2010-10-06

Allergies occur when the defence mechanisms of the immune system malfunction and misread normal substances entering the body as invading pathogens. Antibodies are part of our biochemical arsenal for combating viruses, bacteria, parasites and other alien substances, but during an allergic reaction the antibody, known as IgE, is directed against usually harmless substances such as grass pollen, nuts, pets or eggs. Asthma and allergies are chronic diseases that reduce quality of life and pose an economic burden on society. New parents have therefore previously been asked if ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC